Dominari (NASDAQ:DOMH) CEO Anthony Hayes Acquires 50,000 Shares of Stock

Dominari Holdings Inc. (NASDAQ:DOMH) CEO Anthony Hayes acquired 50,000 shares of the stock in a transaction dated Thursday, September 10th. The shares were bought at an average cost of $2.02 per share, with a total value of $101,000.00. Following the completion of the purchase, the chief executive officer directly owned 4,550,873 shares in the company, valued at approximately $9,192,763.46. This trade represents a 1.11% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Dominari Stock Up 2.3%

DOMH stock opened at $2.23 on Tuesday. The company has a market cap of $54.06 million, a price-to-earnings ratio of -0.41 and a beta of 0.87. The business has a fifty day simple moving average of $2.55 and a 200-day simple moving average of $2.92. Dominari Holdings Inc. has a 52 week low of $1.91 and a 52 week high of $8.40.

Dominari (NASDAQ:DOMH) last issued its earnings results on Monday, August 10th. The company reported ($0.21) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.34) by $0.13. Dominari had a negative return on equity of 235.37% and a negative net margin of 51.61%.The firm had revenue of $16.79 million for the quarter, compared to analysts’ expectations of $16.79 million.

Institutional Trading of Dominari

Several large investors have recently added to or reduced their stakes in DOMH. PFG Investments LLC raised its position in Dominari by 36.3% in the first quarter. PFG Investments LLC now owns 14,475 shares of the company’s stock valued at $47,000 after purchasing an additional 3,855 shares during the period. Renaissance Technologies LLC lifted its stake in shares of Dominari by 59.1% during the first quarter. Renaissance Technologies LLC now owns 132,362 shares of the company’s stock worth $430,000 after purchasing an additional 49,162 shares in the last quarter. Connective Capital Management LLC lifted its stake in shares of Dominari by 112.9% during the second quarter. Connective Capital Management LLC now owns 243,223 shares of the company’s stock worth $764,000 after purchasing an additional 128,994 shares in the last quarter. Finally, Creek Drive Management Group LLC purchased a new stake in shares of Dominari in the fourth quarter worth about $1,861,000. 42.48% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of Dominari in a report on Monday, July 6th. Wall Street Zen lowered shares of Dominari from a “hold” rating to a “sell” rating in a report on Saturday, August 15th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

About Dominari

Dominari Holdings Inc, a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2.